HDIM
YTEN

Hanson & Doremus Investment Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Hanson & Doremus Investment Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10
Closed -$2K – 523
2021
Q2 		$2K Hold
10
– – ﹤0.01% 406
2021
Q1 		$3K Hold
10
– – ﹤0.01% 469
2020
Q4 		$1K Hold
10
– – ﹤0.01% 428
2020
Q3 		$2K Hold
10
– – ﹤0.01% 406
2020
Q2 		$2K Hold
10
– – ﹤0.01% 423
2020
Q1 		$1K Hold
10
– – ﹤0.01% 443
2019
Q4 		$2K Hold
10
– – ﹤0.01% 440
2019
Q3 		$5K Hold
10
– – ﹤0.01% 428
2019
Q2 		$9K Buy
10
+3
+43% +$2.87K ﹤0.01% 425
2019
Q1 		$8K Buy
+7
New +$7.53K ﹤0.01% 410

Other funds holding YTEN

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Hanson & Doremus Investment Management's YTEN Position: Q3 2021 in Review

Hanson & Doremus Investment Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2021, closing a stake of 10 shares — an estimated $2K sold.

Hanson & Doremus Investment Management first reported a position in YTEN in Q1 2019 and held it in 10 quarters. The position peaked at $9K in Q2 2019. 13 funds tracked by Wall St. Rank hold YTEN as of Q3 2021.

  • Hanson & Doremus Investment Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 10 Yield10 Bioscience, Inc. Common Stock shares in Q3 2021, an estimated $2K.
  • Hanson & Doremus Investment Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • Hanson & Doremus Investment Management's Yield10 Bioscience, Inc. Common Stock position peaked at $9K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2021.

Based on Hanson & Doremus Investment Management's 13F filing for Q3 2021, filed 21 Oct 2021.